Literature DB >> 9666934

Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis.

W D Fraser1, F C Logue, J P Christie, S J Gallacher, D Cameron, D S O'Reilly, G H Beastall, I T Boyle.   

Abstract

Several studies have established that the circulating concentration of intact parathyroid hormone, PTH (1-84), over 24 h follows a circadian rhythm. The importance of this circadian rhythm is not known although some authors have detected alterations in the rhythm in metabolic bone disease and following dietary manipulation. We have studied the circadian rhythm of PTH (1-84) in 8 premenopausal women, 8 postmenopausal women with established osteoporosis and 8 postmenopausal women with no evidence of osteoporosis. Blood samples were obtained at 30-min intervals over a 24-h period and significant differences were found in the profiles of PTH (1-84) and serum phosphate in the three groups studied. Premenopausal women possessed a nocturnal/early morning increase in PTH (1-84) and phosphate (between 2200 and 0700 hours), as did postmenopausal women without osteoporosis. In postmenopausal women with osteoporosis the nocturnal increase in PTH (1-84) and serum phosphate was absent and PTH (1-84) decreased during the period 2200-0700 hours. A shift in acrophase is observed between premenopausal and postmenopausal women without osteoporosis. No acrophase was found in postmenopausal women with osteoporosis for either PTH (1-84) or serum phosphate. No circadian rhythm, acrophase or significant amplitude was observed in serum adjusted calcium or ionized calcium in any group studied. Alterations in the circadian rhythms for PTH (1-84) and serum phosphate occur in patients with postmenopausal osteoporosis that suggest that normal dynamics of PTH (1-84) secretion may play a role in both calcium and phosphate metabolism and the bone remodelling process. Whether these changes are causative or a response to the pathology will require further investigation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9666934     DOI: 10.1007/BF02672507

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   5.071


  48 in total

1.  BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE.

Authors:  L G RAISZ
Journal:  J Clin Invest       Date:  1965-01       Impact factor: 14.808

2.  Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis.

Authors:  R Eastell; M S Calvo; M F Burritt; K P Offord; R G Russell; B L Riggs
Journal:  J Clin Endocrinol Metab       Date:  1992-03       Impact factor: 5.958

3.  Diurnal variation of serum calcium and phosphorus in postmenopausal women.

Authors:  H M Perry; M A Province; D M Droke; G S Kim; S Shaheb; L V Avioli
Journal:  Calcif Tissue Int       Date:  1986-02       Impact factor: 4.333

4.  The role of phosphate in the secretion of parathyroid hormone in man.

Authors:  E Reiss; J M Canterbury; M A Bercovitz; E L Kaplan
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

5.  Response of the parathyroid gland to infusion of human parathyroid hormone-(1-34) [PTH-(1-34)]: demonstration of suppression of endogenous secretion using immunoradiometric intact PTH-(1-84) assay.

Authors:  F Cosman; V Shen; B Herrington; R Lindsay
Journal:  J Clin Endocrinol Metab       Date:  1991-12       Impact factor: 5.958

6.  Temporal interrelationships between the circadian rhythms of serum parathyroid hormone and calcium concentrations.

Authors:  M E Markowitz; S Arnaud; J F Rosen; M Thorpy; S Laximinarayan
Journal:  J Clin Endocrinol Metab       Date:  1988-11       Impact factor: 5.958

7.  An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.

Authors:  A B Hodsman; L J Fraher; T Ostbye; J D Adachi; B M Steer
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

8.  Pulse amplitude and frequency modulation of parathyroid hormone in plasma.

Authors:  H M Harms; U Kaptaina; W R Külpmann; G Brabant; R D Hesch
Journal:  J Clin Endocrinol Metab       Date:  1989-10       Impact factor: 5.958

9.  The effect of oral phosphate administration on major indices of skeletal metabolism in normal subjects.

Authors:  S J Silverberg; E Shane; T L Clemens; D W Dempster; G V Segre; R Lindsay; J P Bilezikian
Journal:  J Bone Miner Res       Date:  1986-08       Impact factor: 6.741

10.  Elevated secretion and action of serum parathyroid hormone in young adults consuming high phosphorus, low calcium diets assembled from common foods.

Authors:  M S Calvo; R Kumar; H Heath
Journal:  J Clin Endocrinol Metab       Date:  1988-04       Impact factor: 5.958

View more
  13 in total

1.  Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis.

Authors:  D Michalska; M Luchavova; V Zikan; I Raska; A A Kubena; J J Stepan
Journal:  Osteoporos Int       Date:  2012-03-17       Impact factor: 4.507

2.  Adolescent idiopathic scoliosis and osteopenia).

Authors:  Mariana Chiru
Journal:  Maedica (Buchar)       Date:  2011-01

Review 3.  A Systematic Review of the Circadian Rhythm of Bone Markers in Blood.

Authors:  Sarah Seberg Diemar; Stig Søgaard Dahl; Anders Sode West; Sofie Amalie Simonsen; Helle Klingenberg Iversen; Niklas Rye Jørgensen
Journal:  Calcif Tissue Int       Date:  2022-03-19       Impact factor: 4.333

4.  Diurnal rhythms of vitamin D binding protein and total and free vitamin D metabolites.

Authors:  Kerry S Jones; Jean Redmond; Anthony J Fulford; Landing Jarjou; Bo Zhou; Ann Prentice; Inez Schoenmakers
Journal:  J Steroid Biochem Mol Biol       Date:  2017-07-19       Impact factor: 4.292

5.  Calcium and phosphate balance in adolescents on home nocturnal haemodialysis.

Authors:  Daljit K Hothi; Elizabeth Harvey; Elizabeth Piva; Laura Keating; Donna Secker; Denis F Geary
Journal:  Pediatr Nephrol       Date:  2006-04-01       Impact factor: 3.714

6.  Effect of Ramadan fasting in Saudi Arabia on serum bone profile and immunoglobulins.

Authors:  Suhard M Bahijri; Ghada M Ajabnoor; Anwar Borai; Jumana Y Al-Aama; George P Chrousos
Journal:  Ther Adv Endocrinol Metab       Date:  2015-10       Impact factor: 3.565

Review 7.  Bone mineral density in patients on maintenance dialysis.

Authors:  Csaba Ambrus; Adrienn Marton; Zsofia Klara Nemeth; Istvan Mucsi
Journal:  Int Urol Nephrol       Date:  2009-12-29       Impact factor: 2.370

Review 8.  Role of therapeutic fasting in women's health: An overview.

Authors:  Pradeep M K Nair; Pranav G Khawale
Journal:  J Midlife Health       Date:  2016 Apr-Jun

9.  Ethnic differences in calcium, phosphate and bone metabolism.

Authors:  J Redmond; L M A Jarjou; B Zhou; A Prentice; I Schoenmakers
Journal:  Proc Nutr Soc       Date:  2014-03-12       Impact factor: 6.297

10.  Diurnal Rhythms of Bone Turnover Markers in Three Ethnic Groups.

Authors:  Jean Redmond; Anthony J Fulford; Landing Jarjou; Bo Zhou; Ann Prentice; Inez Schoenmakers
Journal:  J Clin Endocrinol Metab       Date:  2016-06-13       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.